万邦德：关于子公司获得发明专利的公告

Core Viewpoint - Wanbangde announced the receipt of an invention patent certificate from the National Intellectual Property Administration for a new compound and its preparation method, indicating potential advancements in pharmaceutical development [2] Company Summary - Wanbangde's wholly-owned subsidiary, Wanbangde Pharmaceutical Group Co., Ltd., has received a patent for a "disulfide cyclic peptide compound and its preparation method and application," which may enhance its product offerings and competitive edge in the pharmaceutical industry [2]